Home/Filings/4/0001140361-22-000658
4//SEC Filing

Benton Susan 4

Accession 0001140361-22-000658

CIK 0001228627other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:01 PM ET

Size

4.9 KB

Accession

0001140361-22-000658

Insider Transaction Report

Form 4
Period: 2022-01-03
Benton Susan
Director
Transactions
  • Award

    Common Stock

    2022-01-03+2,94929,060 total
Footnotes (1)
  • [F1]The Reporting Person was granted common stock in lieu of cash for Q4 2021 Board services. The number of shares of Common Stock having an aggregate Fair Market Value equal to the aggregate amount of the Retainers for such fiscal quarter, determined by dividing (A) the aggregate amount of the Retainers by (B) the Fair Market Value of the Common Stock on last day of the fiscal quarter (rounded down to the nearest whole share). The Fair Market Value was $3.73 per share, the closing price of the Company's stock on December 31, 2021.

Issuer

Ocuphire Pharma, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001373649

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:01 PM ET
Size
4.9 KB